The feasibility study for screening of early stage of lung cancer by novel urinary biomarker using protein fragments: a prospective study
- Conditions
- Idiopathic pulmonary fibrosis (IPF)
- Registration Number
- JPRN-UMIN000037033
- Lead Sponsor
- niversity of Miyazaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 120
Not provided
1)Patients who have abnormal shadow (more than or equal to 1.0 cm) clinicaly suspected lung cancer by high resolution CT. 2)Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis (more than or equal to 2+). 3)Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 4)Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 5)Patients who is pregnant or who is suspected to be pregnant. 6)Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 7)Patients whose attending physicians consider to be inappropriate for this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method